These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3112014)
21. Effect of T-cell depletion on the growth of BCG in the mouse footpad. Collins FM; Auclair L; Montalbine V Int Arch Allergy Appl Immunol; 1975; 48(5):680-90. PubMed ID: 805768 [TBL] [Abstract][Full Text] [Related]
22. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Flynn JL; Goldstein MM; Triebold KJ; Koller B; Bloom BR Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12013-7. PubMed ID: 1465432 [TBL] [Abstract][Full Text] [Related]
23. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Hormaeche CE Immunology; 1979 Jun; 37(2):311-8. PubMed ID: 381178 [TBL] [Abstract][Full Text] [Related]
24. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis. Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075 [TBL] [Abstract][Full Text] [Related]
25. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. Castillo-Rodal AI; Castañón-Arreola M; Hernández-Pando R; Calva JJ; Sada-Díaz E; López-Vidal Y Infect Immun; 2006 Mar; 74(3):1718-24. PubMed ID: 16495544 [TBL] [Abstract][Full Text] [Related]
26. Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria. Gheorghiu M; Mouton D; Lecoeur H; Lagranderie M; Mevel JC; Biozzi G Clin Exp Immunol; 1985 Jan; 59(1):177-84. PubMed ID: 3882283 [TBL] [Abstract][Full Text] [Related]
27. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis. Hwang SA; Kruzel ML; Actor JK Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854 [TBL] [Abstract][Full Text] [Related]
28. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis. Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of an aerogenic BCG vaccine in T-cell-depleted and normal mice. Morrison NE; Collins FM Infect Immun; 1975 May; 11(5):1110-21. PubMed ID: 123519 [TBL] [Abstract][Full Text] [Related]
34. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. Dannenberg AM Immunobiology; 1994 Oct; 191(4-5):461-73. PubMed ID: 7713560 [TBL] [Abstract][Full Text] [Related]
35. Ipr1 modified BCG as a novel vaccine induces stronger immunity than BCG against tuberculosis infection in mice. Wang Y; Yang C; He Y; Zhan X; Xu L Mol Med Rep; 2016 Aug; 14(2):1756-64. PubMed ID: 27356552 [TBL] [Abstract][Full Text] [Related]
38. Frequencies of IFN gamma- and IL-4-producing cells during Mycobacterium bovis BCG infection in two genetically susceptible mouse strains: role of alpha/beta T cells and NK1.1 cells. Teixeira HC; Munk ME; Kaufmann SH Immunol Lett; 1995 May; 46(1-2):15-9. PubMed ID: 7590911 [TBL] [Abstract][Full Text] [Related]
39. Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium. Ramarathinam L; Niesel DW; Klimpel GR J Immunol; 1993 May; 150(9):3965-72. PubMed ID: 8473743 [TBL] [Abstract][Full Text] [Related]
40. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis. Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]